Status:
COMPLETED
Research of Molecular and Metabolic Markers in Oligodendrogliomas Comparatively to Other Brain Tumours
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Oligodendrogliomas
Eligibility:
All Genders
1+ years
Brief Summary
At present, diagnosis of oligodendroglioma is made on histological and radiographic criteria in the French Mayo-Ste Anne classification. The less frequent grade A oligodendrogliomas are characterized ...
Eligibility Criteria
Inclusion
- Paediatric and adult patients (\> 1 year of age)
- Patient with oligodendroglioma or medulloblastoma or glioma
- Possibility of 3 year follow-up
- Patient consent obtained
Exclusion
- \-
Key Trial Info
Start Date :
February 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
189 Patients enrolled
Trial Details
Trial ID
NCT00213876
Start Date
February 1 2004
End Date
August 1 2011
Last Update
August 30 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Natacha Entz-Werle
Strasbourg, France